Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02119806Phase 4Withdrawn
A Phase 4 trial of midazolam in coronary artery disease (CAD), heart valve disease, sponsored by University of California, Los Angeles. Planned start Aug 2017; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02119806.